Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|3|587-595

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.3, 2018-02, pp. : 587-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design

By Cascione Mark  

Journal of Medical Economics, Vol. 16, Iss. 7, 2013-07 ,pp. : 859-865

Informa Healthcare

Access to resources Recommend Favorite

Long‐term follow‐up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4158-4164

John Wiley & Sons Inc

Access to resources Recommend Favorite

Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

By Pascual Maria Luz G.   Fleming Rosa Rosanna B.   Gana Theophilus J.   Vorsanger Gary J.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2531-2542

Informa Healthcare

Access to resources Recommend Favorite

Long‐term follow‐up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome‐positive acute lymphoblastic leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1013-1020

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 755-768

John Wiley & Sons Inc

Access to resources Recommend Favorite